The combination of three or four pro-inflammatory cytokine polymorphisms affecting IL-1 beta (IL-1B-511T), IL-1 receptor antagonist (IL-1RN*2), TNF alpha (TNF-A-308A) and IL-10 (IL-10 haplotype ATA) results in a highly significant increased risk of development of gastric cancer [ 18 ].
1
—
—